Receive Windhover's unique market insight fast with our free alert
service 'Windhover's Update', including the latest abstracts
and summaries from:
• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight
Sign up
now
|
|
|
|
 |
Windhover conferences provide unparalleled access to key decision makers and today's leading executives. Connect your organization to the most respected and knowledgeable health care information provider by sponsoring a Windhover
event. |
|
PLUS!
- Stand out from the crowd: Elevate your status as a
major player in the industry
- Showcase your intellectual expertise in front of the
most senior level executives in the health care industry
- Meet key prospects and demonstrate your capabilities
- Raise the profile of your company’s image, products, services and partnering
abilities
- Take advantage of Windhover’s powerful direct marketing strategies: Send your
message to tens of thousands of your target executives
- Strengthen your position as a market leader among C-level and senior-level
decision-makers
- Receive multiple passes to attend our conferences. Since many of your co-workers
will be attending anyway, sponsorships are a cost-effective way to maximize
passes to the event while getting additional exposure
|
|
|
For more information contact:
|
Ken
May
Director, Commercial Sales
Elsevier Business Intelligence |
Tel: (914) 332-1419
Mobile: (914) 356-5107
Email: k.may@elsevier.com |
|
|
Alicia McNiven
Director, Advertising & Sponsorships
Elsevier Business Intelligence |
Tel: (215) 646-3778
Mobile: (908) 547-7262
Email: a.mcniven@elsevier.com |
|
|
Sponsors and Partners of Windhover events have included:
|
|
 |
|
 |
|
|
| |
 |
Novartis Follows Its Own Business Development Model into Molecular Diagnostics
Novartis is mirroring its approach to pharma R&D and leveraging the byproducts of its biomarker work there to build a commercial molecular diagnostics franchise. The head of the unit talks about its structure, strategy and programs. . . [MORE] (IN VIVO)
Bioactive Technologies For Bone Replacement
Expanded indications for bone morphogenetic proteins and new alternatives to those first-generation bone growth factors have the potential to grow the $2 billion market for bone replacement materials. . . [MORE] (Start-Up)
Laser Cataract Surgery Comes into Focus at ASCRS
The mood was primarily upbeat at April's annual meeting of the American Society of Cataract and Refractive Surgery. Most in attendance expected a modest rebound in procedure volumes for 2010. . . [MORE] (Medtech Insight)
FDA, Drug Development and Health Care Reform: A Panel Discussion
Current and former FDA officials and a former Big Pharma head of R&D discuss FDA and the relationship between a regulator and the industry it regulates when it comes to drug development. . . [MORE] (The RPM Report)
Read
more from the latest:
IN VIVO,
Start-Up,
The RPM Report,
Medtech Insight, "The Pink Sheet",
"The Pink Sheet" DAILY,
"The Rose Sheet",
"The Tan Sheet",
PharmAsia News,
Pharmaceutical Approvals Monthly, and
"The Gray Sheet".
|
|
|
|
| |
|
|
|
|
|
